News
AstraZeneca, the U.K.-Swedish pharmaceutical giant, on Tuesday announced a plan to invest some $50 billion in the U.S. in a ...
AstraZeneca, a pharmaceutical company, has announced its plans to bring a drug substance manufacturing facility to Virginia.
AstraZeneca's strategic $50B investment promises to revolutionize U.S. medicine production with advanced manufacturing and ...
The company said the Virginia facility "would be AstraZeneca’s largest single manufacturing investment in the world." The ...
The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...
Governor Glenn Youngkin announced Monday that AstraZeneca selected Virginia for a multi-billion-dollar manufacturing center ...
The company plans to invest billions in a new drug manufacturing hub in Virginia, dedicated to chronic disease treatments, alongside additional facilities in California, Indiana, Maryland, ...
AstraZeneca said it would invest $50 billion in U.S. production by 2030. At the core is a manufacturing plant to go somewhere in Virginia.
With the threat of tariffs looming for medicines imported to the United States, AstraZeneca has unveiled a plan to invest $50 ...
President Donald Trump referenced the announcement the following day in Oval Office remarks, framing AstraZeneca’s overall ...
The biopharmaceutical company AstraZeneca announced it will $50 billion into the United States, with plans to open several ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback